home · filing · 0001079973-23-001735
8-K
filed December 12, 2023, 6:59 PM ET
CIK 0001601280
leadership
confidence high
sentiment neutral
materiality 0.40
MediXall appoints Shane Glavin as interim Principal Financial Officer; Noel Guillama resigns
MediXall Group, Inc.
Resignation of Noel Guillama as interim Principal Financial Officer accepted Dec 6, 2023.
Shane Glavin appointed as replacement interim Principal Financial Officer effective same date.
Glavin is CEO of Power CFO, holds an MBA, and has over 20 years of finance and accounting experience.
Glavin previously held CFO roles at LaborMAX Staffing and VP Finance at Midwest Pacific Rail Net & Logistics.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-12-06
Filed December 12, 2023, 6:59 PM ET
appointed Shane Glavin to replace Mr. Guillama
Effective 2023-12-06
Successor Shane Glavin
Filed December 12, 2023, 6:59 PM ET
accepted the written resignation of Noel Guillama as its interim Principal Financial Officer
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Shane Glavin was appointed as interim Principal Financial Officer at MediXall Group, Inc..
Action appointed
Role interim Principal Financial Officer
Exact text from the filing
appointed Shane Glavin to replace Mr. Guillama
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Noel Guillama resigned as interim Principal Financial Officer at MediXall Group, Inc..
Action resigned
Role interim Principal Financial Officer
Exact text from the filing
accepted the written resignation of Noel Guillama as its interim Principal Financial Officer
View on SEC.gov
Source: SEC EDGAR
accession 0001079973-23-001735
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.